Skip to content

The effect of exogenous growth hormone on eyeball refractive development

The effect of exogenous growth hormone on eyeball refractive development

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022841
Enrollment
Unknown
Registered
2019-04-28
Start date
2019-05-11
Completion date
Unknown
Last updated
2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dwarfism

Interventions

Case series:injecting exogenous growth hormone

Sponsors

Aier Institute of Optometry and Vision Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Subject aged between 6 and 13 years old, male or female; 2. The subject and the parent must be able to understand and personally sign the informed consent form; 3. The eye is health.

Exclusion criteria

Exclusion criteria: 1. Allergic to tropamide or local anesthetics; 2. strabismus and/or amblyopia; 3. previous history of ocular surgery (including strabismus surgery); 4. any possibility related to myopia development or affecting refractive state of the eye Eye or systemic disease. For example, Marfan syndrome, retinopathy of prematurity, diabetes, etc.; 5. Any history of ocular trauma or abnormalities of the cornea, conjunctiva and eyelids (including keratoconus and herpetic viral keratitis); 6. Orthokeratologyor or other contact lens; 7. Visual training is currently underway; 8. Any abnormal anatomical structure, skin irritation or other conditions that affect normal glasses.

Design outcomes

Primary

MeasureTime frame
eye axial;Diopter;

Countries

China

Contacts

Public ContactWeizhong Lan

Aier Institute of Optometry and Vision Science

lanweizhong@aierchina.com+86 13725458845

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026